Connect with us
Novartis has acquired global rights to develop, manufacture, and commercialize Leqvio under a licensing and collaboration agreement with Alnylam Pharmaceuticals, which is a leader in RNA...
PharmaMar wanted to highlight the growth in royalty income, which has increased by 8% compared to the same period of the previous year, reaching a total...
The agreement between the two companies allows Debiopharm to access licensing options to continue the development of SunRock Biopharma's antibodies, integrating Debiopharm's innovative conjugation technologies, called...
Almirall is a global biopharmaceutical company focused on medical dermatology. We collaborate with scientists and healthcare professionals to address patient needs through science to improve their...
The Viennese biotech company has developed a type of vaccine based on genetically modified arenaviruses. In the case of HB-200, these are vectors based on the...
Euroespes was listed on BME Growth for twelve years, but because of its entry into bankruptcy proceedings, the regulator has suspended its listing. Before the suspension,...
The agreement signed between Microsoft and Ribera also involves collaboration with Futurs, the technological subsidiary of the Ribera Group, which thus becomes a partner of the...
Almirall will obtain a license to use EpimAb's patented Fabs-In-Tandem Immunoglobulin (FIT-Ig) platform. The Spanish pharmaceutical company reduced its profit by 56% in the first half...
Through the application of advanced "digital twin" technology, PrediSurge enables physicians and MedTech companies to refine intervention strategies and optimize medical device design. A system that,...
BioNTech 's turnover in 2022 was €17.31 billion, which represented a decrease of 8.8%. By business segments, those from the marketing of medicines amounted to €17.2...
 |
|
 |  |
 |
|